Mitochondria are dynamic, double-membrane-bound organelle of eukaryotic cells that have evolved to function in a wide range of cellular processes. They are responsible for oxidative phosphorylation (OXPHOS), producing energy and metabolites, regulating apoptosis and maintaining cell viability. To properly perform these functions, mitochondria depend on hundreds of proteins which are encoded in the nucleus, synthesized in the cytosol, and imported into the organelle. The transport of mitochondrial preproteins is mainly mediated by the translocase of the outer mitochondrial membrane and the translocase of the inner mitochondrial membrane [1] . Given the dependence of mitochondrial function on cytosolic synthesized proteins, maintaining efficient mitochondrial protein import is indispensable for cellular and organismal health. Therefore, it is not surprising that some sophisticated protective responses must exist to defend against deficient mitochondrial protein import in cells.
Recently, a few mitochondria-to-nucleus signaling pathways were uncovered, including mitochondrial unfolded protein response (mtUPR) [2] , unfolded protein response activated by mistargeting of proteins (UPRam) [3] , and mitochondrial precursor overaccumulation stress (mPOS) [4] . In Caenorhabditis elegans, mtUPR is activated by the accumulation of unfolded protein within the mitochondrial matrix. As a result, mtUPR induces initiation of a nuclear encoded stress program including the transcriptional activation of mitochondrial stress proteins. mtUPR has been shown to play an important role in the mitochondrial protein quality control system [2, 5] . UPRam was identified as a beneficial mechanism in yeast that protects cells against mitochondrial import defect and over-accumulation of mitochondrial precursor proteins in the cytosol. UPRam activation inhibits protein synthesis and triggers the proteasome for cellular protein clearance, which is governed by the Irc25-Poc4 complex [3] . A recent genetic study in yeast revealed a novel protective mechanism named mPOS against mitochondrial protein import deficiency. mPOS is a novel pathway of proteostatic stress-mediated cell death due to mitochondrial dysfunction. mPOS is triggered by mitochondrial damage and the aberrant accumulation of mitochondrial precursors in the cytosol. Consequently, mPOS reduces the translation of unimported proteins via upregulating ribosome-associated proteins including Gis2 and Nog2 [4] . Recently, mitoCPR was found in budding yeast. mitoCPR is a novel cellular response to defective mitochondrial protein import that protects mitochondrial functions [6] . All the above pathways provide a nuclear response to counteract the adverse effects of compromised mitochondrial functions ( Table 1) .
MitoCPR is known as mitochondrial compromised protein import response [6] . Upon mitochondrial import stress, mitoCPR is triggered to restore mitochondrial import and plays a critical role in maintaining mitochondria functions. This protective process is mediated by the activation of the transcription factor, PDR3 as well as its downstream transcriptional effector, Cis1. Cis1 recruits the adenosine triphosphatase Msp1 to import channels on the mitochondrial outer membrane through binding to the translocase receptor Tom70. These proteins facilitate the removal and proteasomal degradation of unimported precursors located on the mitochondrial surface and translocase. This discovery reveals that mitoCPR serves as a novel beneficial pathway to keep mitochondrial protein homeostasis and mitochondrial functions during mitochondrial import stress. The identification of mitoCPR widens the mitochondria responses against accumulation of mitochondrial precursor proteins outside the organelle and further highlights the central role of mitochondrial import in mitochondrial functions.
Multiple lines of evidence indicate a causative role of mitochondrial import defects in mitochondrial dysfunction and pathologies. Devi et al. [7] suggested that the accumulation of amyloid precursor protein (APP) inside the mitochondrial import channels, is a driving force for mitochondrial dysfunction and contributes to the pathology of Alzheimer's disease (AD). The cell adhesion molecule L1 is an important regulator in the nervous system under physiological conditions. L1 cleavage product, L1-70, was shown to be imported from the cytoplasm into mitochondria and to be important for mitochondrial functions. Blocking the mitochondrial import of L1-70, impairs mitochondrial membrane potential, disrupts mitochondrial dynamics and causes some nervous system injuries as well as neurodegenerative diseases [8] . These discoveries suggested that protein import perturbations are common in neurodegenerative diseases and may induce mitochondrial damage. Therefore, it is important to trigger mitochondrial protective pathways such as mitoCPR to maintain the functionality of mitochondrial protein import and prevent neurodegenerative diseases (Fig. 1) . It is unclear yet whether mitoCPR exists in mammals and if so why it is not sufficient to rescue the import problems? It is possible that the mitochondrial damage in these diseases is too severe or that mitoCPR can not be activated for prolonged periods but is just activated transiently.
The transcription factor, activating transcription factor associated with stress-1 (ATFS-1), modulates another pathway of mitochondriato-nuclear communication. ATFS-1 is a key regulator in sensing mitochondrial stress. During mitochondrial stress, the mitochondrial import efficiency of ATFS-1 is reduced, causing the nuclear accumulation of ATFS-1 and mtUPR activation. Consequently, the impaired OXPHOS machinery and mitochondrial dysfunction caused by import stress are significantly restored [9, 10] . Thus, the import efficiency of ATFS-1 into mitochondria has a profound impact on the recovery of defective OXPHOS and mitochondria. The essential OXPHOS components are encoded by mitochondrial DNA (mtDNA), which reveals a tight correlation between mtUPR and PDR3-mediated mitoCPR [5] . mitoCPR prevents the rapid loss of mitochondrial DNA [6, 11] , hinting the participation of mitoCPR in preventing mitochondrial damage. These observations indicate the preventive links between mitoCPR and mitochondrial import defects, as well as some pathologies related to mitochondrial import defects, such as neurodegenerative diseases and mitochondrial dysfunction (Fig. 1) .
As previously stated, the mitochondrial import stress is attributable to a large amount of unimported proteins accumulating on mitochondrial surface and in the import channel due to the compromised mitochondrial import. Thus, the process of clearance and proteasomal degradation of precursors is an especially critical step of mitoCPR to maintain mitochondrial function. Paasch et al. [12] showed that SUMO modification of mitochondrial proteins could be promoted by defective mitochondrial import and proteostasis failure. Similarly, the ubiquilin family of proteins mediates the degradation of mitochondrial transmembrane proteins thus preventing the accumulation of non-inserted mitochondrial precursors [13] . These results demonstrate the involvement of modifications such as SUMOylation and ubiquitination in the quality control of mitochondrial proteins.
The question remains, whether SUMOylation and ubiquitination are involved in the mitoCPR-mediated proteasomal degradation of unimported proteins.
Future studies should focus on identifying the activating signals of mitoCPR, as well as its specific regulatory pathway. It is possible that metabolic intermediates, presumably accumulating in the cytoplasm when mitochondrial import is defected, activate PDR3. It is also possible that specific unimported proteins activate PDR3. Notably, PDR3 up-regulates the expressions of genes encoding ABC Figure 1 . The involvement of mitochondrial import defect and lower mitoCPR in mitochondrial dysfunction and neurodegenerative disorder MitoCPR is activated by PDR3, which induces the expression of Cis1 and recruits Msp1 to import channels, thereby facilitating the proteasomal degradation of unimported precursors located in mitochondria's surface and translocase. The defective import of APP and L1-70 into mitochondria could lead to their abnormal accumulation inside the mitochondrial import channels. As a result, mitoCPR is reduced, thereby inducing mitochondrial dysfunction and neurodegenerative diseases. ATFS-1 is a key regulator in sensing mitochondrial stress. During mitochondrial stress, the mitochondrial import efficiency of ATFS-1 is disturbed, restoring the nuclear accumulation of ATFS-1, attenuating the defective OXPHOS and mitochondrial dysfunction. OXPHOS components are encoded by mtDNA, which is protected by PDR3-mediated mitoCPR. Therefore, mitoCPR is involved in preventing mitochondrial import defects, as well as some pathologies such as neurodegenerative diseases and mitochondrial dysfunction. PDR3, pleiotropic drug-resistant 3; Cis1, cytokine-inducible SH2-containing protein; Msp1, the AAA+ adenosine triphosphatase; APP, amyloid precursor protein; L1-70, a 70 kDa fragment of molecule L1; ATFS-1, activating transcription factor associated with stress-1; mtDNA, mitochondrial DNA; OXPHOS, oxidative phosphorylation machinery.
transporters and NADPH-dependent enzymes, which implies an additional role of mitoCPR in restoring redox potential and compensating for lipid biosynthesis. It is also indicative of the potential links between mitoCPR and removing metabolic intermediates, which has yet to be determined.
Although mitoCPR is activated by the overexpressions of bipartite signal-containing proteins, it is likely to occur under pathological conditions, since stress conditions indeed occur in some diseases. mitoCPR may be particularly important upon mitochondrial import overload state, such as the situations of rapid expanding mitochondrial compartment. Collectively, mitoCPR is an important mitochondrial protective mechanism responsible for maintaining mitochondrial functions during mitochondrial import stress. This pathway may play a vital role in mitochondrial dysfunction and neurodegenerative disorder. Therefore, drugs targeted to reverse the process of mitochondrial import stress and stimulate the emergence of mitoCPR may open a new avenue to hold back the adverse effects in mitochondria and inhibit the development of neurodegenerative disorder.
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